KOD - Kodiak Sciences Inc Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
12.35 2.53 (20.49%) --- --- -0.06 (-0.38%) 0.01 (0.08%) 2.26 (17.88%) -0.01 (-0.07%) -0.01 (-0.07%)

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
-1.09
Diluted EPS:
-1.09
Basic P/E:
-13.6514
Diluted P/E:
-13.6514
RSI(14) 1m:
100.0
VWAP:
14.84
RVol:

Events

Period Kind Movement Occurred At

Related News